Inergio 's green power units are already meeting customer needs, marking the start of exciting growth for the startup headquartered in Renens. Recently, the CEO and founder Mahmoud Hadad celebrated ...

Legacy financial institutions, such as Germany’s oldest bank, Bankhaus Metzler, and global asset manager BlackRock, are integrating solutions from Swiss fintech startups to boost efficiency. Meanwhile ...

Several Swiss start-ups have secured the necessary funds to conquer global markets.

The Mission for Essential Drugs and Supplies (MEDS) in Kenya and CHAN Medi-Pharm in Nigeria, as well as Ecumenical Pharmaceutical Network (EPN) have joined forced with Swiss startup Axmed to improve ...

Major companies in the automotive, energy and agriculture sector are relying on Swiss startups to reach their CO2 emissions targets, achieve efficiency in electricity network monitoring and enable ...

With 37 new spin-offs, ETH Zurich continues its long-term upward trend in the launch of new companies from its research.

Helix Robotics is developing the first commercial soft robot manipulator, addressing the need for human-friendly and reliable robotics. By combining the safety of soft robotics with industrial ...

Swiss startup Oxyle announced a $16m funding round to scale its breakthrough solution to destroy, not just relocate, PFAS from wastewater. This builds on its $3M pre-seed round in 2022, growing ...

BioVersys started the offer period of its newly issued shares. Based on the offer price, the implied market capitalization of BioVersys is about CHF 212.9 million. Listing and first day of trading on ...

Startups supported by Venture Kick have made remarkable achievements, with 66 Venture Kick alumni recognized among the TOP 100 Swiss Startups 2024. And despite a difficult fundraising environment, the ...

Yokoy, the leading spend management platform, has been acquired by TravelPerk, a business travel platform based in Barcelona. In parallel, TravelPerk announced the closing of a financing round in ...

AB2 Bio has entered into an option and licensing agreement with Nippon Shinyaku Co. Ltd., a leading Japanese pharmaceutical company with extensive experience in marketing rare disease therapeutics in ...